Revuforj is designed to treat patients with relapsed or refractory mutant NPM1 acute myeloid leukemia. The application has been assigned a real-time oncology review, which allows for a more efficient ...

JB Chemicals & Pharmaceuticals announced that it has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Amitriptyline ...

JB Chemicals share price will reman in focus on June 25 following the company received USFDA approval for its Amitriptyline ...

The initiative, referred to as the Commissioner’s National Priority Voucher program, allows drug developers to participate in a novel FDA priority program. The program significantly shortens the FDA ...

The FDA's new genAI-assisted scientific review technology, named Elsa, was officially adopted by the agency on 2 June.

Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts.

Chemistry falls under the umbrella of natural sciences, alongside other fields like biology, geology and physics. Chemistry ...

HONG KONG SAR - Media OutReach Newswire - 25 June 2025 - Genomic medicine is one of the most promising fields in today's healthcare landscape, enabling precise diagnoses, personalised treatment plans, ...

Convening Experts to Promote Hong Kong and Advance Medical InnovationHONG KONG SAR - Media OutReach Newswire - 25 June 2025 - Genomic medicine is one of the most promising ...

In a Phase I/II clinical trial, TKI-pretreated NSCLC patients given zidesamtinib had an overall response rate of 44 percent.